OAC
STRO icon

OMERS Administration Corp’s Sutro Biopharma STRO Stock Holding History

OMERS Administration Corp’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
8,700
-2,323
-21% -$42K ﹤0.01% 899
2025
Q4 		$128K Buy
11,023
+1,508
+16% +$14.3K ﹤0.01% 952
2025
Q3 		$82.6K Hold
9,515
– – ﹤0.01% 1065
2025
Q2 		$67.9K Hold
9,515
– – ﹤0.01% 824
2025
Q1 		$61.9K Hold
9,515
– – ﹤0.01% 988
2024
Q4 		$175K Sell
9,515
-9,515
-50% -$290K ﹤0.01% 884
2024
Q3 		$658K Buy
+19,030
New +$746K 0.01% 602

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OMERS Administration Corp's STRO Position: Q1 2026 in Review

OMERS Administration Corp reduced its Sutro Biopharma (STRO) stake by 21% in Q1 2026, selling an estimated $42K and leaving 8,700 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

OMERS Administration Corp first reported a position in STRO in Q3 2024 and has held it in 7 quarters since. The position peaked at $658K in Q3 2024. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • OMERS Administration Corp held 8,700 shares of Sutro Biopharma worth $217K as of Q1 2026.
  • OMERS Administration Corp sold 2,323 Sutro Biopharma shares in Q1 2026, an estimated $42K.
  • Sutro Biopharma made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #899 holding.
  • OMERS Administration Corp first reported a position in Sutro Biopharma in Q3 2024 and has held it in 7 quarters since.
  • OMERS Administration Corp's Sutro Biopharma position peaked at $658K in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.